I made an enquiry to LC (about trials etc..I have sadly had 3 friends diagnosed recently) last week and she responded promptly which I was thankful for. She is a great human and I’m very happy she is the CEO personally.
She provided some updates to me as well..
“HER-Vaxx studies have completed, and studies have been closed. The data continues to be published and presented.
PD1-Vaxx is in a Phase 1 trial, known as Neo-POLEM is an Investigator Sponsored Trial (IST) and will recruit patients in sites in Australia and the UK. The trial is expected to recruit approximately 44 patients with colorectal cancer. Treatment with PD1-Vaxx will be administered before surgery (neoadjuvant)
Preliminary early data are expected in the first half of 2025.
The B-cell immunotherapies have been deprioritized to focus on the azer-cel program and the Oncolytic Virus platftience rm. Management continues to pursue out-licensing opportunities for its B-cell immunotherapies.”
The process is definitely frustrating for LTH but I’m content to wait for results and slowly add a little more while the SP is so low.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)